STOCKHOLDERS' EQUITY (Tables)

3 Months Ended

Mar. 31, 2022

STOCKHOLDERS' EQUITY

Schedule of transaction and other information relating to stock options

				Weighted-Average
				Remaining	Aggregate
	Number of	Weighted-Average		Contractual Term	Intrinsic
	Options	Exercise Price		(In Years)	Value
Outstanding at December 31, 2021	3,771,000	$	2.18	5.68	$	4,660,000
Grants	7,000	$	3.63	—		—
Exercised	—	$	—	—		—
Forfeited/cancelled/expired/settled	—	$	—	—		—
Balance as of March 31, 2022	3,778,000	$	2.18	5.44	$	11,270,000
Vested and expected to vest at March 31, 2022	3,777,000	$	2.18	5.44	$	11,270,000
Unvested at March 31, 2022	11,000	$	7.26	9.51	$	—
Exercisable at March 31, 2022	3,767,000	$	2.16	5.43	$	11,270,000

Schedule of transaction and other information relating to restricted stock grants

		Average
		Fair Value
		at Grant
	Shares	Date
Unvested at December 31, 2021	76,000	$	3.90
Grants	7,000	$	3.63
Vested	(7,000)	$	3.63
Forfeited/cancelled/expired	—	$	—
Unvested at March 31, 2022	76,000	$	3.90